Publications by authors named "Renata Tataj"

Article Synopsis
  • The study aimed to explore the genetic and clinical diversity of patients with Dravet syndrome (DRVT) in Poland, focusing on seizure types and associated developmental issues.
  • Researchers analyzed data from 50 patients, finding high rates of intellectual disability (71%) and some autism (18%), but no clear link between specific genetic mutations and the clinical severity of symptoms.
  • Key findings suggest that early indicators, such as age of first seizure and specific seizure characteristics, can help differentiate DRVT from other seizure disorders, improving diagnosis and treatment strategies.
View Article and Find Full Text PDF

Studies conducted on large populations show a lack of connection between vaccination and serious neurological symptoms. However, there are isolated cases that indicate such a relationship. These reports on adverse effects following immunization (AEFI) reduce social confidence in vaccination; however, their background may be rare genetic defects.

View Article and Find Full Text PDF

Friedreich ataxia (FRDA) is the most common hereditary ataxia. It is an autosomal recessive disorder caused by mutations of the FXN gene, mainly the biallelic expansion of the (GAA)n repeats in its first intron. Heterozygous expansion/point mutations or deletions are rare; no patients with two point mutations or a point mutation/deletion have been described, suggesting that loss of the FXN gene product, frataxin, is lethal.

View Article and Find Full Text PDF

Objective: The aim of this study was to analyze the intra-/interfamilial phenotypic heterogeneity due to variants at the highly evolutionary conservative p.Arg1596 residue in the Nav1.1 subunit.

View Article and Find Full Text PDF

Unlabelled: Diseases caused by mutations in SCN1A are currently named Genetic Epilepsies with Febrile Seizures Plus, and this term stands for expanded spectrum of syndrome previously called as GEFS+ (Generalized Epilepsy with Febrile Seizures Plus). SCN1A is the uniquely identified gene directly linked to specific type of epilepsy, and its testing has been included in the screening processes.

The Aim: To diagnose and describe epileptic syndromes caused by SCN1A mutations.

View Article and Find Full Text PDF